Clinical Trial Confirms Benefit Of Targeted Lung Cancer Therapy
Links shared publicly online about this topic.
- 241total visits
Clinical Trial Confirms Benefit Of Targeted Lung Cancer Therapy
View full resource at medicalnewstoday.com
Tags: Cancer, Lung Cancer, Lung, Drug, Clinical Trial
Most Recently Shared on June 5, 2011 at 10:06 am By:
Clinical Trial Confirms Benefit Of Targeted Lung Cancer Therapy http://mnt.to/3WLV #clinicaltrials
Also Shared By:
Medical oncologists confirm benefits of crizotinib in ALK positive lung cancer
news-medical.net — “A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and the results from the largest group of patients to take it within the first of these clinical trials are being presented at the annual meeting of the American Society of Clinical Oncology.” View full resource at news-medical.net
Most Recently Shared on June 4, 2011 at 5:42 am By:
Medical oncologists confirm benefits of crizotinib in ALK positive lung cancer: A drug that targets a specific t... http://bit.ly/l6duZ8
Benefit of targeted lung cancer therapy confirmed
eurekalert.org — “A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and the results from the largest group of patients to take it within the first of these clinical trials are being presented at the annual meeting of the American Society of Clinical Oncology.” View full resource at eurekalert.org
Most Recently Shared on June 3, 2011 at 11:27 pm By:
Benefit of targeted lung cancer therapy confirmed: ( University of Colorado Denver ) A drug that targets a speci... http://bit.ly/jDjgeT
Benefit of targeted lung cancer therapy confirmed
sciencedaily.com — “A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, researchers are now reporting the results from the largest group of patients to take it within the first of these clinical trials.” View full resource at sciencedaily.com
Most Recently Shared on June 3, 2011 at 8:16 pm By:
Benefit of targeted lung cancer therapy confirmed: A drug that targets a specific type of lung cancer shows a dramatic.. http://dld.bz/acfTb
Vandetanib shows clinical benefit when combined with docetaxel for lung cancer
physorg.com — “When combined with standard chemotherapy, an international Phase III trial has shown that the oral targeted therapy vandetanib improves progression-free survival for patients with advanced non-small cell lung cancer, according to research from The University of Texas M. D. Anderson Cancer Center.” View full resource at physorg.com
Most Recently Shared on June 1, 2009 at 2:24 pm By:
Vandetanib shows clinical benefit when combined with docetaxel for lung cancer http://tinyurl.com/lqswv2
Advertisement
MNT Lung Cancer
@mnt_lungcancer
Clinical Trial Confirms Benefit Of Targeted Lung Cancer Therapy http://mnt.to/3WLV #lungcancer
1 year ago...